Azurity Announces Plans to Commercialize D-PLEX100 in the U.S. and Canada through Exclusive Partnership with PolyPid
Woburn, MA, July 21, 2026 (GLOBE NEWSWIRE) — Azurity Pharmaceuticals, a privately held specialty pharmaceutical company, today announced…